— Know what they know.
Not Investment Advice

ACLX NASDAQ

Arcellx, Inc.
1W: +0.0% 1M: +0.2% 3M: +68.6% YTD: +81.7% 1Y: +77.8% 3Y: +180.7%
$115.07
Last traded 2026-05-15 — delisted
NASDAQ · Healthcare · Biotechnology · $6.7B mcap · 43M float · 3.37% daily turnover · Short 30% of daily vol

Balance Sheet Trends

Total Assets
$604M -15.1% ▼
5Y CAGR: +59.9%
Total Liabilities
$202M -21.4% ▼
5Y CAGR: +95.0%
Shareholders Equity
$402M -11.5% ▼
5Y CAGR: +51.4%
Cash & Investments
$450M -23.3% ▼
5Y CAGR: +57.4%
Total Debt
$96M +78.0% ▲
Net Debt
$16M +131.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$31M$64M$395M$106M$80M
Short-Term Investments$74M$191M$307M$482M$370M
Cash & ST Investments$105M$255M$702M$587M$450M
Net Receivables$0$0$0$0$4M
Inventory$0$0$0$0$0
Other Current Assets$2M$4M$8M$6M$8M
Total Current Assets$113M$267M$716M$599M$462M
Property, Plant & Equip.$10M$40M$70M$70M$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$27M$38M$72M
Other Non-Current Assets$6M$7M$12M$3M$69M
Total Non-Current Assets$16M$47M$109M$112M$142M
Total Assets$129M$314M$825M$711M$604M
— Liabilities —
Accounts Payable$1M$9M$3M$2M$6M
Short-Term Debt$0$0$0$0$8M
Deferred Revenue$0$0$51M$59M$0
Other Current Liabilities$6M$8M$14M$19M$91M
Total Current Liabilities$15M$57M$118M$125M$104M
Long-Term Debt$0$0$0$0$44M
Other Non-Current Liab.$235M$0$0$9M-$44M
Total Non-Current Liabilities$235M$52M$222M$131M$97M
Total Liabilities$250M$109M$340M$257M$202M
— Equity —
Common Stock$1K$44K$52K$53K$56K
Retained Earnings-$130M-$319M-$389M-$497M-$726M
Accumulated OCI-$20K-$221K$547K$848K$843K
Total Stockholders Equity-$122M$205M$485M$455M$402M
Total Liabilities & Equity$129M$314M$825M$711M$604M
— Key Metrics —
Total Debt$0$88M$98M$54M$96M
Net Debt-$31M$24M-$297M-$52M$16M
Total Investments$74M$191M$335M$520M$442M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms